Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CO2 Carbonylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN118638089B enables CO2-based flavonoid synthesis. Offers high yield, mild conditions, and supply chain advantages for pharmaceutical intermediates.
Solve high-cost, low-yield issues in minodronic acid synthesis. New halogenation-Grignard method offers 83-88% yield, no toxic reagents, and scalable production for osteoporosis drugs.